Logo image of RBX.CA

ROBEX RESOURCES INC (RBX.CA) Stock Fundamental Analysis

TSX-V:RBX - TSX Venture Exchange - CA76125Y6001 - Common Stock - Currency: CAD

3.22  +0.09 (+2.88%)

Fundamental Rating

4

Taking everything into account, RBX scores 4 out of 10 in our fundamental rating. RBX was compared to 818 industry peers in the Metals & Mining industry. RBX has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, RBX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

RBX had negative earnings in the past year.
RBX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RBX reported negative net income in multiple years.
In the past 5 years RBX always reported a positive cash flow from operatings.
RBX.CA Yearly Net Income VS EBIT VS OCF VS FCFRBX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

RBX has a Return On Assets (-10.18%) which is in line with its industry peers.
RBX has a Return On Equity of -15.98%. This is comparable to the rest of the industry: RBX outperforms 57.53% of its industry peers.
RBX has a better Return On Invested Capital (13.54%) than 96.76% of its industry peers.
RBX had an Average Return On Invested Capital over the past 3 years of 12.03%. This is significantly below the industry average of 24.74%.
The 3 year average ROIC (12.03%) for RBX is below the current ROIC(13.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -10.18%
ROE -15.98%
ROIC 13.54%
ROA(3y)2.28%
ROA(5y)11.24%
ROE(3y)2.59%
ROE(5y)14.71%
ROIC(3y)12.03%
ROIC(5y)19.03%
RBX.CA Yearly ROA, ROE, ROICRBX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

RBX has a better Operating Margin (27.66%) than 94.77% of its industry peers.
RBX's Operating Margin has improved in the last couple of years.
RBX has a better Gross Margin (96.29%) than 99.75% of its industry peers.
Industry RankSector Rank
OM 27.66%
PM (TTM) N/A
GM 96.29%
OM growth 3Y-8.9%
OM growth 5Y3.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBX.CA Yearly Profit, Operating, Gross MarginsRBX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

RBX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for RBX has been increased compared to 1 year ago.
Compared to 5 years ago, RBX has less shares outstanding
RBX has a better debt/assets ratio than last year.
RBX.CA Yearly Shares OutstandingRBX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RBX.CA Yearly Total Debt VS Total AssetsRBX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.13 indicates that RBX is not in any danger for bankruptcy at the moment.
The Altman-Z score of RBX (3.13) is better than 62.02% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that RBX is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.13, RBX is not doing good in the industry: 63.26% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 3.13
ROIC/WACC1.53
WACC8.82%
RBX.CA Yearly LT Debt VS Equity VS FCFRBX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

RBX has a Current Ratio of 0.52. This is a bad value and indicates that RBX is not financially healthy enough and could expect problems in meeting its short term obligations.
RBX has a worse Current ratio (0.52) than 68.62% of its industry peers.
RBX has a Quick Ratio of 0.52. This is a bad value and indicates that RBX is not financially healthy enough and could expect problems in meeting its short term obligations.
RBX has a Quick ratio of 0.39. This is in the lower half of the industry: RBX underperforms 69.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.39
RBX.CA Yearly Current Assets VS Current LiabilitesRBX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The earnings per share for RBX have decreased strongly by -15981.48% in the last year.
The Revenue has grown by 17.71% in the past year. This is quite good.
Measured over the past years, RBX shows a quite strong growth in Revenue. The Revenue has been growing by 9.81% on average per year.
EPS 1Y (TTM)-15981.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.15%
Revenue 1Y (TTM)17.71%
Revenue growth 3Y15.09%
Revenue growth 5Y9.81%
Sales Q2Q%15.7%

3.2 Future

RBX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -11.25% yearly.
The Revenue is expected to grow by 66.91% on average over the next years. This is a very strong growth
EPS Next Y-64.08%
EPS Next 2Y23.66%
EPS Next 3Y-11.25%
EPS Next 5YN/A
Revenue Next Year-28.77%
Revenue Next 2Y108.8%
Revenue Next 3Y66.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RBX.CA Yearly Revenue VS EstimatesRBX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
RBX.CA Yearly EPS VS EstimatesRBX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.1 0.2 0.3

2

4. Valuation

4.1 Price/Earnings Ratio

RBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 42.25, RBX can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, RBX is valued cheaply inside the industry as 88.04% of the companies are valued more expensively.
RBX is valuated expensively when we compare the Price/Forward Earnings ratio to 20.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 42.25
RBX.CA Price Earnings VS Forward Price EarningsRBX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RBX is valued cheaper than 95.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.36
RBX.CA Per share dataRBX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A cheap valuation may be justified as RBX's earnings are expected to decrease with -11.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.66%
EPS Next 3Y-11.25%

0

5. Dividend

5.1 Amount

No dividends for RBX!.
Industry RankSector Rank
Dividend Yield N/A

ROBEX RESOURCES INC

TSX-V:RBX (5/9/2025, 7:00:00 PM)

3.22

+0.09 (+2.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-28 2025-04-28
Earnings (Next)05-28 2025-05-28
Inst Owners32.27%
Inst Owner ChangeN/A
Ins Owners3.63%
Ins Owner ChangeN/A
Market Cap542.57M
Analysts84
Price Target4.49 (39.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-3.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.15%
PT rev (3m)11.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)42.31%
EPS NY rev (3m)80.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)18.18%
Revenue NY rev (3m)32.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 42.25
P/S 2.75
P/FCF N/A
P/OCF 11.57
P/B 2.13
P/tB 2.13
EV/EBITDA 5.36
EPS(TTM)-0.43
EYN/A
EPS(NY)0.08
Fwd EY2.37%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.28
OCFY8.64%
SpS1.17
BVpS1.51
TBVpS1.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.18%
ROE -15.98%
ROCE 20.91%
ROIC 13.54%
ROICexc 15.79%
ROICexgc 15.82%
OM 27.66%
PM (TTM) N/A
GM 96.29%
FCFM N/A
ROA(3y)2.28%
ROA(5y)11.24%
ROE(3y)2.59%
ROE(5y)14.71%
ROIC(3y)12.03%
ROIC(5y)19.03%
ROICexc(3y)12.9%
ROICexc(5y)21.3%
ROICexgc(3y)12.93%
ROICexgc(5y)21.33%
ROCE(3y)19.03%
ROCE(5y)28.34%
ROICexcg growth 3Y-24.44%
ROICexcg growth 5Y-12.48%
ROICexc growth 3Y-24.47%
ROICexc growth 5Y-12.5%
OM growth 3Y-8.9%
OM growth 5Y3.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 0.36
Cap/Depr 203.19%
Cap/Sales 41.1%
Interest Coverage 11.29
Cash Conversion 49.57%
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.39
Altman-Z 3.13
F-Score3
WACC8.82%
ROIC/WACC1.53
Cap/Depr(3y)263.2%
Cap/Depr(5y)246.88%
Cap/Sales(3y)42.52%
Cap/Sales(5y)37.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15981.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.15%
EPS Next Y-64.08%
EPS Next 2Y23.66%
EPS Next 3Y-11.25%
EPS Next 5YN/A
Revenue 1Y (TTM)17.71%
Revenue growth 3Y15.09%
Revenue growth 5Y9.81%
Sales Q2Q%15.7%
Revenue Next Year-28.77%
Revenue Next 2Y108.8%
Revenue Next 3Y66.91%
Revenue Next 5YN/A
EBIT growth 1Y8.27%
EBIT growth 3Y4.85%
EBIT growth 5Y13.61%
EBIT Next Year34.47%
EBIT Next 3Y117.39%
EBIT Next 5YN/A
FCF growth 1Y-365.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.96%
OCF growth 3Y2.21%
OCF growth 5Y0.45%